ADAMIS PHARMACEUTICALS CORP's ticker is ADMP and the CUSIP is 00547W208. A total of 49 filers reported holding ADAMIS PHARMACEUTICALS CORP in Q1 2022. The put-call ratio across all filers is 0.09 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $13,238 | -23.7% | 114,218 | +11.4% | 0.00% | – |
| Q4 2022 | $17,356 | -13.2% | 102,518 | +0.1% | 0.00% | – |
| Q3 2022 | $20,000 | -62.3% | 102,369 | -3.5% | 0.00% | – |
| Q2 2022 | $53,000 | -15.9% | 106,071 | -3.8% | 0.00% | – |
| Q1 2022 | $63,000 | -24.1% | 110,228 | -19.6% | 0.00% | – |
| Q4 2021 | $83,000 | -18.6% | 137,163 | +30.7% | 0.00% | – |
| Q3 2021 | $102,000 | -9.7% | 104,950 | +2.3% | 0.00% | – |
| Q2 2021 | $113,000 | +18.9% | 102,545 | +1.8% | 0.00% | – |
| Q1 2021 | $95,000 | +93.9% | 100,745 | +0.1% | 0.00% | – |
| Q4 2020 | $49,000 | -39.5% | 100,620 | -2.9% | 0.00% | – |
| Q3 2020 | $81,000 | +44.6% | 103,620 | 0.0% | 0.00% | – |
| Q2 2020 | $56,000 | +51.4% | 103,620 | -1.0% | 0.00% | – |
| Q1 2020 | $37,000 | -51.3% | 104,620 | -3.8% | 0.00% | – |
| Q4 2019 | $76,000 | -48.3% | 108,720 | -47.7% | 0.00% | – |
| Q3 2019 | $147,000 | -85.1% | 207,689 | -72.6% | 0.00% | – |
| Q2 2019 | $984,000 | +78.6% | 757,124 | +189.7% | 0.00% | – |
| Q1 2019 | $551,000 | +58.3% | 261,331 | +69.0% | 0.00% | – |
| Q4 2018 | $348,000 | -26.6% | 154,647 | +14.0% | 0.00% | – |
| Q3 2018 | $474,000 | +27.1% | 135,683 | +16.6% | 0.00% | – |
| Q2 2018 | $373,000 | -71.5% | 116,343 | -68.8% | 0.00% | – |
| Q1 2018 | $1,307,000 | +111.8% | 373,411 | +166.1% | 0.00% | – |
| Q4 2017 | $617,000 | +67.7% | 140,310 | +99.4% | 0.00% | – |
| Q3 2017 | $368,000 | +97.8% | 70,367 | +96.7% | 0.00% | – |
| Q2 2017 | $186,000 | -15.5% | 35,781 | -30.6% | 0.00% | – |
| Q1 2017 | $220,000 | +46.7% | 51,562 | +8.8% | 0.00% | – |
| Q4 2016 | $150,000 | +21.0% | 47,412 | +31.0% | 0.00% | – |
| Q3 2016 | $124,000 | +552.6% | 36,180 | +454.4% | 0.00% | – |
| Q2 2016 | $19,000 | -52.5% | 6,526 | -1.9% | 0.00% | – |
| Q1 2016 | $40,000 | +37.9% | 6,650 | +22.6% | 0.00% | – |
| Q4 2015 | $29,000 | +7.4% | 5,426 | -21.0% | 0.00% | – |
| Q3 2015 | $27,000 | +125.0% | 6,871 | +148.9% | 0.00% | – |
| Q2 2015 | $12,000 | +200.0% | 2,761 | +191.9% | 0.00% | – |
| Q1 2015 | $4,000 | +300.0% | 946 | +370.6% | 0.00% | – |
| Q4 2014 | $1,000 | -66.7% | 201 | -65.2% | 0.00% | – |
| Q3 2014 | $3,000 | +200.0% | 577 | +187.1% | 0.00% | – |
| Q2 2014 | $1,000 | – | 201 | +957.9% | 0.00% | – |
| Q1 2014 | $0 | -100.0% | 19 | -99.2% | 0.00% | – |
| Q4 2013 | $15,000 | – | 2,354 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Greenlight Capital | 292,366 | $283,000 | 0.02% |
| Virtu Financial LLC | 204,870 | $199,000 | 0.02% |
| Verdence Capital Advisors LLC | 143,382 | $139,000 | 0.02% |
| Founders Capital Management | 18,000 | $17,000 | 0.01% |
| WOLFF WIESE MAGANA LLC | 10,740 | $10,000 | 0.01% |
| Global Strategic Investment Solutions, LLC | 23,000 | $22,000 | 0.00% |
| Belvedere Trading LLC | 118,500 | $146,000 | 0.00% |
| Affinity Capital Advisors, LLC | 13,180 | $13,000 | 0.00% |
| Atom Investors LP | 56,492 | $55,000 | 0.00% |
| Stonebridge Capital Advisors LLC | 22,000 | $21,000 | 0.00% |